Information Regarding Development Activities. Eisai shall maintain, or cause to be maintained, records of the clinical trials and other development work, in sufficient detail and in good scientific manner appropriate for patent and regulatory purposes, which shall fully and properly reflect all work done and results achieved by or on behalf of Eisai in the performance of such clinical trials and other development work under this Agreement or the Existing Agreement. Eisai shall retain such records during the Term and for at least five years after the Term, or for such longer period as may be required by Applicable Laws.
Appears in 2 contracts
Sources: Transaction Agreement, Transaction Agreement (Arena Pharmaceuticals Inc)